About
Medo.ai is a health-focused artificial intelligence startup founded in 2018, with dual headquarters in Edmonton, Canada, and Singapore. The company specializes in AI-augmented 3D ultrasound technology that enhances the use of ultrasound imaging for diagnosing various medical conditions. Their core product is an AI-powered ultrasound platform that automates image acquisition and interpretation, making it easier for users, even those with limited training, to perform accurate ultrasound exams. The proprietary Sweep AI™ technology integrated into their ultrasound devices helps detect conditions like developmental dysplasia of the hip and thyroid abnormalities by optimizing image selection for diagnosis. Medo.ai aims to democratize medical imaging, particularly in remote and rural areas, by making ultrasound accessible anytime and anywhere. The company has developed FDA-cleared AI algorithms and collaborates with leading health systems globally to promote clinical adoption of their technology. In 2022, Medo.ai was acquired by Exo, which aims to further enhance the accessibility and ease of use of ultrasound imaging.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2017
-
Annual Revenue $2000000
Location
10359 104 St NW, Edmonton, Alberta, Canada, T5J 1B9